# An Observational Study to Evaluate the Efficacy of Lodoz in a Population of Hypertensive Patients

> **NCT01080742** · — · COMPLETED · sponsor: **Merck KGaA, Darmstadt, Germany** · enrollment: 1007 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Lodoz (Combination of bisoprolol and hydrochlorothiazide)

## Key facts

- **NCT ID:** NCT01080742
- **Lead sponsor:** Merck KGaA, Darmstadt, Germany
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2011-06
- **Final completion:** 2011-12
- **Target enrollment:** 1007 (ACTUAL)
- **Last updated:** 2014-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01080742

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01080742, "An Observational Study to Evaluate the Efficacy of Lodoz in a Population of Hypertensive Patients". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT01080742. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*